IP Library Granted Patent US 7,294,126
Granted Patent B2
US 7,294,126 · App. 10/751,592 · Granted Nov 13, 2007

Apparatus and method for treating venous reflux

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,294,126
App. No.
10/751,592
Granted
Nov 13, 2007
Kind
B2
Abstract

Disclosed is an ablation method and apparatus used to close veins for treatment of venous insufficiency disease. The apparatus includes a catheter proportioned for insertion into a vein, a pair of inflatable balloons spaced apart on the catheter body, and an ablation electrode array disposed between the balloons. According to the disclosed method, the catheter is introduced into the vein to be treated and the balloons are distended. Blood is flushed and aspirated from the site between the balloons. RF power is applied to the electrode array, causing scarring of the vessel walls and eventual sealing of the vein.

Claims (31)

1. A device for sealing a blood vessel, comprising:

a catheter having an elongate body positionable within a blood vessel, the elongate catheter body selectively collapsible to a reduced diameter configuration to facilitate movement of the catheter within a blood vessel;

a pair of inflatable balloon members on the elongate body, the balloon members expandable into contact with an interior wall of the blood vessel;

a bipolar electrode array on the elongate body between the balloons;

at least one opening in the elongate body, between the balloons;

a source of flushing fluid coupled to the opening;

a vacuum source fluidly coupled to the opening, the vacuum source providing sufficient vacuum pressure to aspirate blood and flushing fluid out of the blood vessel through the opening; and

a source of ablation energy electrically coupled to the electrode array such that energization of the electrode array causes ablation of blood vessel tissue in contact with the electrode array.

2. The device of claim 1 wherein the vacuum source is further operable to draw the interior wall of the blood vessel into contact with the electrode array.

3. The device of claim 1 wherein the vacuum source is further operable to draw moisture generated during ablation away from the tissue and into the elongate body.

4. The device of claim 1 wherein the at least one opening comprises a plurality of openings in the elongate body.

5. The device of claim 1 wherein the source of ablation energy includes an RF generator having a low impedance transformation circuit and a high impedance transformation circuit, an impedance detection circuit for measuring impedance of tissue in contact with the electrode array, and a control circuit for automatically selecting between the low impedance transformation circuit and the high impedance transformation circuit based on the impedance of the tissue in contact with the electrode array.

6. The device of claim 5 wherein the control circuit is for selecting the transformation circuit having an impedance closest to the measured impedance of the tissue in contact with the electrode array.

7. The device of claim 1 , wherein the catheter includes a collapsible lumen, the lumen collapsible after ablation to place the catheter in the reduced-diameter configuration and to facilitate removal of the catheter from the vessel.

8. A device for sealing a blood vessel, comprising:

a catheter having an elongate body positionable within a blood vessel, the elongate catheter body selectively collapsible to a reduced diameter configuration to facilitate movement of the catheter within a blood vessel, the catheter including a collapsible lumen;

a pair of inflatable balloon members on the elongate body, the balloon members expandable into contact with an interior wall of the blood vessel;

an electrode array on the elongate body between the balloons;

at least one opening in the elongate body, between the balloons;

a source of flushing fluid coupled to the opening;

a vacuum source fluidly coupled to the opening, the vacuum source providing sufficient vacuum pressure to aspirate blood and flushing fluid out of the blood vessel through the opening the vacuum source fluidly coupled to the collapsible lumen; and

a source of ablation energy electrically coupled to the electrode array such that energization of the electrode array causes ablation of blood vessel tissue in contact with the electrode array.

9. The device of claim 1 , wherein the device includes a compression device positionable exteriorly of the blood vessel for compression of the blood vessel following ablation, said compression sufficient to cause opposed ablated regions of the interior wall to seal against one another.

10. A device for sealing a blood vessel, comprising:

a catheter having an elongate body positionable within a blood vessel;

a pair of inflatable balloon members on the elongate body, the balloon members expandable into contact with an interior wall of the blood vessel;

an electrode array on the elongate body between the balloons;

at least one opening in the elongate body, between the balloons;

a source of ablation energy electrically coupled to the electrode array such that energization of the electrode array causes ablation of blood vessel tissue in contact with the electrode array; and

a vacuum source fluidly coupled to the opening, the vacuum source operable during ablation of blood vessel tissue to substantially prevent formation of a low impedance liquid layer around the electrodes when ablation is carried out using the electrodes.

11. The device of claim 10 wherein the electrode array is a bipolar electrode array.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 25, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024944/0315 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: CYTYC SURGICAL PRODUCTS
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021311/0118 →
PATENT SECURITY AGREEMENT Recorded Oct 26, 2007
From: CYTYC SURGICAL PRODUCTS
To: GOLDMAN SACHS CREDIT PARTNERS L.P.
Reel/Frame 020018/0653 →
CHANGE OF NAME Recorded Nov 12, 2004
From: NOVACEPT
To: CYTYC SURGICAL PRODUCTS
Reel/Frame 015991/0624 →